Leuprorelin acetate Prescribing at PRIORY MEDICAL GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
345
Total Quantity
348
NHS Cost
£61.4K
vs National Avg
+644.5%
PRIORY MEDICAL GROUP prescribed 345 items of Leuprorelin acetate over the last 12 months at a cost of £61,351 to the NHS. This is 644.5% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
44
Jul 2026
23
Jul 2026
31
Jul 2026
21
Jul 2026
26
Jul 2026
28
Jul 2026
29
Jul 2026
36
Jul 2026
31
Jul 2026
27
Jul 2026
28
Jul 2026
21
Prescribing Details
| Total Items | 345 |
|---|---|
| Total Quantity | 348 |
| Total NHS Cost | £61,351 |
| Presentations | 3 different forms |
| vs National Average | +644.5% |
Leuprorelin acetate Prescribing Comparison
| This practice | 345 items |
|---|---|
| National average per practice | 46 items |
| Difference | +644.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.